Back
X4 Pharmaceuticals Vs. Amylyx Pharmaceuticals Industry Stock Comparison
Buy
53
XFOR
X4 Pharmaceuticals
Last Price:
1.15
Seasonality Move:
-25.36%
Sell
20
AMLX
Amylyx Pharmaceuticals
Last Price:
2.04
Seasonality Move:
89.63%
Buy
53
X4 Pharmaceuticals (XFOR)
is a Buy
Is X4 Pharmaceuticals a Buy, Sell or Hold?
- The current X4 Pharmaceuticals [XFOR] share price is $1.15. The Score for XFOR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- XFOR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $2.03. The Score for AMLX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
XFOR Stock Price Chart
What is X4 Pharmaceuticals's stock price today?
-
The X4 Pharmaceuticals share price today is $1.15
The current trend is relatively stagnant and XFOR is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $2.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing selling pressure, which indicates risk of future bearish movement.
XFOR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 47.41 | Sell |
Chaikin Money Flow: | 2110404 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.15 - 1.37) | Sell |
Bollinger Bands (100): | (0.75 - 1.21) | Buy |
AMLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.84 | Sell |
Relative Strength Index (14 RSI): | 29.35 | Sell |
Chaikin Money Flow: | -793057 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 2.5) | Sell |
Bollinger Bands (100): | (3.86 - 17.2) | Sell |
XFOR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.14 | Buy |
20-day SMA: | 1.22 | Sell |
50-day SMA: | 1.15 | Sell |
200-day SMA: | 1.04 | Buy |
8-day EMA: | 1.15 | Buy |
20-day EMA: | 1.19 | Sell |
50-day EMA: | 1.15 | Buy |
200-day EMA: | 1.11 | Buy |
AMLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.89 | Buy |
20-day SMA: | 2.06 | Sell |
50-day SMA: | 5.75 | Sell |
200-day SMA: | 14.43 | Sell |
8-day EMA: | 1.95 | Buy |
20-day EMA: | 2.36 | Sell |
50-day EMA: | 5.18 | Sell |
200-day EMA: | 13.49 | Sell |
X4 Pharmaceuticals Earnings Growth & XFOR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.00 per share, an increase this year of $0.17 per share, and a decrease next year of $0.00 per share.
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.96 per share, an increase next quarter of $0.09 per share, a decrease this year of $2.52 per share, and an increase next year of $0.28 per share.
X4 Pharmaceuticals Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amylyx Pharmaceuticals Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |